Progesterone transdermal - Dimera

Drug Profile

Progesterone transdermal - Dimera

Alternative Names: DP 9

Latest Information Update: 30 Nov 2015

Price : $50

At a glance

  • Originator Dimera
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Myocardial ischaemia

Highest Development Phases

  • Phase II Myocardial ischaemia

Most Recent Events

  • 30 Nov 2015 Progesterone transdermal - Dimera is available for licensing (ww.dimera.net)
  • 27 Nov 2015 Phase-II clinical trials in Myocardial ischaemia (Prevention of relapse, Prevention) in USA (Transdermal)
  • 22 Jul 2013 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top